Dr. Micha Abeles is a dedicated rheumatologist, currently serving the Meriden area of Connecticut. He is a highly experienced medical professional, board certified in both rheumatology and internal medicine for over 4 decades. Throughout his over 40 years of practice, Dr. Micha Abeles has garnered much recognition and praise, not only his community, but nationwide.

Dr. Micha Abeles has been a respected mentor to doctors nationwide and continues to share his experience and expertise 40 years later. During his years as a professor of medicine at the University of Connecticut Heath Center, Dr. Abeles established quite the reputation as a groundbreaking researcher. Throughout his near 4 decades of practice, Dr. Micha Abeles oversaw numerous clinical trials leading development of significant medications that are still in use today. Amongst his research, Dr. Abeles demonstrated the effectiveness of phosphodiesterase type 5 inhibitors in treating Buerger disease and methotrexate in treating rheumatoid arthritis. During this time, Dr. Abeles was able to conduct some original research of his which ultimately lead way to him being a co-author of the 1990 fibromyalgia criteria paper. The paper was the first study that was able to fully define the syndrome. Additionally, Dr. Micha Abeles, along with co-investigators, were amongst the first to associate the use of steroids and avascular necrosis of bone.

Dr. Micha Abeles’ career in rheumatology only began in 1976, after leaving the U.S. Army. During his time in the force, Dr. Abeles served as a major and chief of the outpatient department at Ft. Monroe VA, from 1974-1976. Over the course of those two years, Dr. Abeles received much recognition and praise for his outstanding clinical skills and his ability to boost moral in the unit.  After leaving the force, he took a fellowship in rheumatology at UConn, where he continued to serve in numerous capacities, including chief of rheumatology.

Dr. Abeles’ skills and discoveries are undoubtedly unparalleled. His unprecedented work as a medical professional has been rightfully acknowledged nationwide. He has been voted Top Doctor in Connecticut for over two decades now, in addition to being listed as Best Doctor and Castle Connolly top doctor for several years. Today, Dr. Micha Abeles practices both rheumatology and internal medicine at his private practice in Meriden, Connecticut.


Corticosteroids Proven Safer than NSAID to for Gout Patients

For the treatment of inflammation, doctors usually recommend one of two routes: NSAID pain relievers, or corticosteroids. NSAIDs, or non-steroidal anti-inflammatory drugs in their non-acronymic form, encompass standard painkillers like Ibuprofen and Aspirin.

Read More

How Express Scripts’ Shutdown of Some Drugs Will Affect Osteoporosis Patients

The nation’s largest mail-order pharmaceutical company, Express Scripts, has reported their plans to no longer continue to carry 64 formerly covered prescription drugs, due to a recent spike in cost. Some popular brands such as Pfizer’s Xeljanz, a pill that treats rheumatoid arthritis; the injectable diabetes drug that is a product of Novo Nordisk; and the inhaler by GlaxoSmithKline, Breo Elipta. This change will even affect older brands such as Bayer’s Betaseron which treats multiple sclerosis.

Read More

Your Gout Medicines May Work Better If You’re Married

For patients with gout, being married appears to increase urate-lowering therapy adherence, according to a study published by Xin Hui Jasmine Chua, Siriwan Lim, Fui Ping Lim, and Yee Nah Anita Lim, in the June 15 edition of Journal of Clinical Nursing, which in an international online journal that serves as the voice of nursing research, theory and practice.

Read More

Medicines May Help to Prevent Arthritis

Every year The European League Against Rheumatism (EULAR), which is an E.U.-based organization that represents the patient, healthcare professional and professional societies of rheumatology, holds the Annual European Congress of Rheumatology. This forum serves as a space where rheumatology professionals can connect with patient organizations, as well as to learn and engage with other professionals in rheumatology, all to achieve progress in the care of people who suffer from various autoimmune and inflammatory diseases.

Read More

About the Decision not to Take Osteoporosis Medications

Multiple factors contribute to the decision not to take osteoporosis medications, with fear of adverse events topping the list, say researchers in a paper published online in the Journal of the American Pharmacists Association.

Read More